Novel compounds as inhibitors of hepatitis C virus NS3 serine protease

Details for Australian Patent Application No. 2005222056 (hide)

Owner Schering Corporation

Inventors Bogen, Stephane L.; Venkatraman, Srikanth; Chen, Kevin X.; Saksena, Anil K.; Bennett, Frank; Sannigrahi, Mousumi; Girijavallabhan, Viyyoor M.; Padilla-Acevedo, Angela I.; Jao, Edwin; Arasappan, Ashok; Njoroge, F. George

Agent Griffith Hack

Pub. Number AU-A-2005222056

PCT Pub. Number WO2005/087725

Priority 60/548,535 27.02.04 US

Filing date 24 February 2005

Wipo publication date 22 September 2005

International Classifications

C07K 5/065 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

14 September 2006 PCT application entered the National Phase

  PCT publication WO2005/087725 Priority application(s): WO2005/087725

19 February 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005222058-Removal of permanganate reducing compounds from methanol carbonylation process stream

2005222055-Compounds as inhibitors of hepatitis C virus NS3 serine protease